Lichen Planus in Subtropical Countries

Dostrovsky, A.; Sagher, F.

doi:10.1001/archderm.1949.01520280060007

Cited by 38 publications

(20 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The condition chiefly affects people age 30 to 60 years (1)(2)(3)(4)(5). Although in tropical countries the younger age groups are affected, it is extremely uncommon in infancy and childhood (5)(6)(7)(8)(9)(10)(11)(12). Familial hchen planus, which is rarely described, also occurs at a younger age (13)(14)(15).…”

Section: Discussionmentioning

confidence: 99%

Lichen Planus in Childhood: A Report of 17 Patients

Kanwar

Handa

Ghosh

et al. 1991

Pediatric Dermatology

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Lichen Planus in Childhood: A Report of 17 Patients

Kanwar

Handa

Ghosh

et al. 1991

Pediatric Dermatology

View full text Add to dashboard Cite

show abstract

“…Actinic LP has a marked predilection for individuals from Middle Eastern countries where many have found it to be common in children. [22][23][24] It is apparently rare in the United States.…”

Section: Actinic Lpmentioning

confidence: 99%

Lichenoid eruptions in children

Tilly

Drolet

Esterly

2004

Journal of the American Academy of Dermatology

113

118

View full text Add to dashboard Cite

“…Zosteriform LP follows dermatomal lines and is thought to be an isotopic response to herpes zoster or at least showing antigens against varicella zoster virus in lesional skin [16,17,18]. Lichen planus pigmentosus-inversus is suggested to be a rare variant of LP limited to intertriginous regions and seems to have a short inflammatory phase with fast transformation into a long noninflammatory regressive phase with brown, nonpruritic, small inflammatory macules; scaling is limited [19,20,21,22,23,24,25]. Only one case of coexistence of classic LP and lichen planus pigmentosus-inversus has been described [26].…”

Section: Discussionmentioning

confidence: 99%

Oral, Esophageal and Cutaneous Lichen Ruber Planus Controlled with Alitretinoin: Case Report and Review of the Literature

Kolios¹,

Maggio²,

Gubler

et al. 2013

Dermatology

View full text Add to dashboard Cite

Background: Therapy-resistant lichen planus (LP) can be a challenging condition for dermatologists. There are some case reports about successful treatments with alitretinoin of cutaneous and oral, but not of esophageal LP. Objective: We present the unique case of a patient with cutaneous, oral and esophageal LP which was refractory to classical treatment options (topical clobetasol propionate and pimecrolimus, intramuscular triamcinolone acetonide); because of systemic side effects the patient did not tolerate systemic acitretin dosed up to 25 mg daily. Methods: Oral alitretinoin was used at a dose of 30 mg daily. Results: Both oral and skin changes as well as dysphagia completely resolved within 4 weeks without any severe side effects and the drug was used for 6 months. No papules, intraoral striae or dysphagia recurred during the 6 months of treatment. After 4 months the patient relapsed with mucosal patches so that a second cycle was initiated for 6 months where oral LP lesions resolved after 4 weeks also (with sporadic mild headache). Conclusion: Further studies are needed to better understand the impact of alitretinoin in LP. Our observation suggests alitretinoin as a new, well-tolerated treatment option for esophageal LP after failed response to conventional treatments.

show abstract

Lichen Planus in Subtropical Countries

Cited by 38 publications

References 21 publications

Lichen Planus in Childhood: A Report of 17 Patients

Lichen Planus in Childhood: A Report of 17 Patients

Lichenoid eruptions in children

Oral, Esophageal and Cutaneous Lichen Ruber Planus Controlled with Alitretinoin: Case Report and Review of the Literature

Contact Info

Product

Resources

About